Dr. Kim Eagle provides a weekly tip for clinicians on the front lines of the COVID-19 pandemic. Findings from the large RECOVERY trial suggest high-titer convalescent plasma has no therapeutic benefit for patients hospitalized with COVID-19. Please visit the ACC COVID-19 Hub for additional resources and information.

Clinical Topics: COVID-19 Hub

Keywords: EaglesEyeView, ACC COVID-19 Podcast, COVID-19, Coronavirus, Coronavirus Infections, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, Plasma

< Back to Listings